Literature DB >> 19100635

Long-term outcome after a first episode of heart failure. A prospective 7-year study.

Christophe Tribouilloy1, Otilia Buiciuc, Dan Rusinaru, Dorothée Malaquin, Franck Lévy, Marcel Peltier.   

Abstract

BACKGROUND: Heart failure (HF) is a major issue of public health in contemporary aging populations. The objectives of the present study were to assess the long-term survival of a contemporary cohort of patients discharged after a first hospitalization for HF and identify variables associated with adverse outcome.
METHODS: We prospectively included consecutive patients (n=735) discharged from 11 healthcare establishments of the Somme department (France) after a first hospitalization for HF during 2000. The 7-year observed survival was compared with the expected survival of the general population.
RESULTS: Mean age of the study group was 75+/-12 years and 48% of patients were women. Left ventricular ejection fraction was measured in 628 patients (85%). During the 7-year follow-up, 483 patients (67%) died. The 5- and 7-year observed survival rates were dramatically lower than the expected survival of the matched general population (42% vs. 70%, and 33% vs. 59%, respectively). Relative survival (observed/expected survival) was 60% at 5 years and 55% at 7 years. Multivariable analysis identified cancer, stroke, diabetes, prior myocardial infarction, chronic obstructive pulmonary disease, chronic atrial fibrillation, age, and hyponatraemia as independent predictors of 7-year mortality.
CONCLUSIONS: In Europe, the long-term outcome of patients with new-onset HF is still extremely poor. Better implementation of guideline-oriented therapeutic strategies is needed to improve prognosis of this increasingly prevalent condition. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19100635     DOI: 10.1016/j.ijcard.2008.11.087

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.

Authors:  Geoffrey T Jao; Jun R Chiong
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

2.  Tolvaptan increases serum sodium in pediatric patients with heart failure.

Authors:  Rebecca B Regen; Ashley Gonzalez; Kasey Zawodniak; David Leonard; Raymond Quigley; Aliessa P Barnes; Joshua D Koch
Journal:  Pediatr Cardiol       Date:  2013-03-05       Impact factor: 1.655

3.  Age- and gender-specific risk of death after first hospitalization for heart failure.

Authors:  I Vaartjes; A W Hoes; J B Reitsma; A de Bruin; D E Grobbee; A Mosterd; M I Bots
Journal:  BMC Public Health       Date:  2010-10-22       Impact factor: 3.295

4.  Effects of Hyponatremia Normalization on the Short-Term Mortality and Rehospitalizations in Patients with Recent Acute Decompensated Heart Failure: A Retrospective Study.

Authors:  Renato De Vecchis; Marco Di Maio; Giuseppina Di Biase; Carmelina Ariano
Journal:  J Clin Med       Date:  2016-10-22       Impact factor: 4.241

5.  Association between borderline dysnatremia and mortality insight into a new data mining approach.

Authors:  Yannick Girardeau; Anne-Sophie Jannot; Gilles Chatellier; Olivier Saint-Jean
Journal:  BMC Med Inform Decis Mak       Date:  2017-11-22       Impact factor: 2.796

6.  Educational attainment and differences in relative survival after acute myocardial infarction in Norway: a registry-based population study.

Authors:  Søren Toksvig Klitkou; Knut R Wangen
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.